Introduction
============

Lumbar disk degeneration (LDD) results in bone instability, compression of neural elements and reduction of spinal canal dimensions, which seriously affect the quality of life of patients ([@b1-mmr-16-06-9487]). LDD is generally caused by genetic, environmental, mechanical and other external factors ([@b2-mmr-16-06-9487],[@b3-mmr-16-06-9487]). At present, the treatment of LDD includes non-surgical treatment and surgical intervention, the purposes of which are to reduce pain ([@b4-mmr-16-06-9487]). The surgical methods include the removal of intervertebral disc lesions and intervertebral disc arthroplasty, without addressing the inherent loss of disc functions ([@b5-mmr-16-06-9487]). Fusion surgery has been identified as a viable treatment option for reducing chronic low back pain due to LDD for patients refractory to nonsurgical care ([@b6-mmr-16-06-9487]). A previous study indicated that LDD may be affected by genetic factors, and that gene therapy may become the future direction of LDD treatment ([@b7-mmr-16-06-9487]).

Wild-type *p53*-induced protein phosphatase 1 (*Wip1*) is a serine/threonine protein phosphatase and a proto oncogene, which belongs to the protein phosphatase 2C family ([@b8-mmr-16-06-9487]). *Wip1*, coded by phosphatase Mg^2+^-dependent 1δ, is aberrantly amplified in different types of primary cancer in humans, and its deletion in mice has been found to result in a profound tumor-resistant phenotype ([@b8-mmr-16-06-9487]). In the presence of Mg^2+^ and other divalent cations, *Wip1* is directly involved in the dephosphorylation and inactivation of proteins downstream of *p53*, thereby inhibiting the DNA repair and apoptosis functions mediated by *p53* in damaged cells ([@b9-mmr-16-06-9487],[@b10-mmr-16-06-9487]). Adeno-associated virus (AAV) is a human virus with low immunogenicity, which can attach to human chromosomes precisely and steadily; therefore, AVV can be used as a stable and safe carrier for exogenous genes ([@b11-mmr-16-06-9487],[@b12-mmr-16-06-9487]). AAV vectors have been used in the treatment of several diseases and have become one of the most promising gene therapy vectors ([@b13-mmr-16-06-9487]). The present aimed to examine the clinical efficacy of *Wip1* delivered by an AAV vector in targeted therapy for LDD.

Materials and methods
=====================

### Ethical statement

The animal experiments were designed with the approval of the Animal Ethics Committee of Shanghai Changzheng Hospital (Shanghai, China) and all experiments were performed in accordance with the international standard ([@b14-mmr-16-06-9487]).

### Experimental subjects

A total of 84 healthy adult New Zealand white rabbits (Hubei Academy of Medical Sciences, Hubei, China) were selected for the experiments, regardless of gender. Their weights ranged between 2.5 and 3 kg, and their ages ranged between 4 and 6 months. The rabbits were adaptively fed for 3 days prior to the experiments and were housed at 21--23°C and 60±5% humidity with a 12-h light/dark cycle. During feeding, the rabbits received a rationed intake of food and water at regular intervals. The temperature, humidity and ventilation conditions were recorded to ensure the health of the rabbits.

### Construction of Wip1 gene vector

A recombinant adenovirus vector for *Wip1* (Ad*Wip1*) was constructed by the Transformation Research Laboratory of the Second Military Medical University (Shanghai, China), which included a green fluorescent protein (GFP) expression cassette. The recombinant adenovirus vector for GFP (AdGFP) expressed GFP only. The vectors were diluted with PBS to 5×10^5^ pfu/µl.

*In vitro* culture of intervertebral disc nucleus pulposus cells. A total of six rabbits were sacrificed prior to the removal of the lumbar spine, which was soaked in 75% of alcohol for 5 min and washed in 0.9% saline three times. The fiber rings in the intervertebral disc, between L1-L2 and L6-L7 were exposed under sterile conditions, revealing the nucleus pulposus tissues. The gel-like tissues were collected using metal tweezers and transferred into 5 ml centrifuge tubes. The tissue samples were washed by centrifugation in Dulbecco\'s minimum essential medium (DMEM), at 200 × g and 4°C for 5 min (model 800; SMEW, Shanghai, China). The samples were then digested in 0.25% type II collagenase (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA) for 20--25 min at 37°C, vibrated for 5 min and washed again by centrifugation in DMEM three times at 200 × g and 4°C for 5 min. Finally, 1% of hyaluronic acid enzyme (Sigma; Merck Millipore, Darmstadt, Germany) was added to the samples and the cell numbers were counted in an automated cell counter (Vi-Cell XR; Beckman Coulter, Inc., Brea, CA, USA). The cells were then seeded at a density of 1.4×10^5^ cells/ml into 24-well culture plates, and cultured at 37°C with 5% CO~2~ in DMEM containing 10% fetal bovine serum (FBS).

### Determination of transfection efficiency

The culture solution was replaced every 3 days until the cells had completely fused; following which 0.25% trypsin was used to digest the cells for subculture. When the cells reached 80% confluence, the cells were removed from the culture medium. The recombinant adenovirus vector Ad*Wip1* was added to the cells at 25, 50, 100, 200, 400 and 800 multiplicity of infection (MOI), and incubated at 37°C with 5% CO~2~. After 1 h, the supernatant liquid was discarded, and fresh cell culture medium (DMEM+10% FBS) was added into each well with 10 mM sodium butyrate. The transfection efficiency was measured using flow cytometry.

### Detection of cell growth and activity

The highest transfection efficiency and the optimal transfection concentration were detected using flow cytometry. The cells were divided into two groups: Recombinant vector *Wip1* group and blank control group. In the *Wip1* group, culture medium was removed and 200 MOI of *Wip1* vector was added into each well. The cells were incubated at 37°C with 5% CO~2~ for 1 h. The liquid supernatant was then discarded, and fresh DMEM containing 10% FBS medium was added with 10 mM sodium butyrate. In the blank control group, the cells were cultured with DMEM+10% FBS only. The growth of the cells was observed using a light microscope. At 1, 3, 5, 7, 9, 11 and 14 days post-transfection, the cells were counted and the cell growth curve was drawn.

Expression of Ad*Wip1* in nucleus pulposus tissues. A total of six rabbits were randomly selected for establishment of the animal model by annulus fibrosus of intervertebral disc injury ([@b15-mmr-16-06-9487]). The rabbits were placed under anesthesia using an intravenous injection of 3% pentobarbital sodium, and the L2-3, L3-4 and L4-5 intervertebral disc regions were exposed by median incision of the abdomen and peritoneum. An injection needle (size 7) was used to puncture the annulus, following which the needle was withdrawn. If the puncture site leaked out some nucleus pulposus fluid, the surgery was complete. The intervertebral space was marked by suture marks on lumbar muscles. The incision was closed at the end of surgery. The normal diet and activities of the rabbits were maintained in the postoperative period. At 4 weeks following surgery, the Ad*Wip1* vectors were injected. At 1, 7, 14, 21 and 28 days post-injection, nucleus pulposus tissues in the lumbar intervertebral disc region were removed and pressed into slides. The fluorescence intensity of the tissues was observed using a fluorescence microscope, and the gene expression level of *Wip1* was analyzed using HPIAS 2000 image analysis software (Tongji Qianping Company, Wuhan, China). The pathological sections of the nucleus pulposus tissues were observed on the slides under an optical microscope.

### Model establishment and grouping

A total of 72 rabbits were randomly divided into two primary groups, with each primary group further divided into three sub-groups. The first primary group included rabbits subjected to intervertebral disc injury by annulus fibrosus, and was further divided into groups A-C. The second primary group was the blank control group and was further divided into groups D-F. At 4 weeks following model establishment, the intervertebral disc (L2-3, L3-4 and L4-5) was exposed through left extra-peritoneal puncture. The Ad*Wip1* vectors were injected into the rabbits in groups A and D. Empty vectors were injected into the rabbits in groups B and E. PBS was injected into the rabbits in groups C and F.

### X-ray examination of the lumbar spine

At 3, 6 and 9 weeks following the second surgical procedure, the rabbits in each group underwent X-ray examinations. The rabbits were maintained at the same depth of anesthesia during the examinations. A computed radiograph machine (Siemens AG, Munich, Germany) was used with the following scanning parameters: 50 kV, 100 mA and 50 mS. Following acquisition of X-ray images, Centricity DICOM viewer 3.1.1 software (GE Healthcare Life Sciences, Little Chalfont, UK) was used to enlarge the images and measure the relevant parameters according to the referenced method ([@b16-mmr-16-06-9487]). The anterior and posterior heights, and the intermediate heights of surgical segments L2-3, L3-4 and L4-5 were measured, and the average of these three values was calculated as the height of the intervertebral disc.

### Determination of proteoglycan contents in the nucleus pulposus

A total of six rabbits in each group were randomly selected and sacrificed by ear venous air embolism. Their lumbar spines were removed and intervertebral discs (L2-3, L3-4 and L4-5) were separated. At each time point, the nucleus pulposus tissues from six intervertebral discs in each group were obtained. The tissues were placed in centrifuge tubes of 4 ml in size. In each sample, 1 ml of 3% NaOH solution was added and incubated on an oscillator (Yunyan Instrument, Shanghai, China) at 40°C for 3 h. Subsequently, 4 ml of HCl was added into each sample to adjust the pH value to 8--9, and 100 µl of 100 mg/ml trypsin was added and incubated on the oscillator at 50°C for 2 h. In the subsequent step, 30 ml of glacial acetic acid, and 10 ml of 50 mg/ml trihydroxybenzene and ethanol solution were mixed with 40 ml of HCl to prepare the trihydroxybenzene solutions. Following enzymolysis, the samples were transferred into a 10 ml volumetric flask and were diluted to the 10 ml constant volume. Using a dropper, 1 ml of the diluted sample solution was transferred into another 10 ml volumetric flask, to which 3 ml trihydroxybenzene solution was added and mixed. The mixture was heated in boiling water for 30 min prior to cooling in ice water for 5 min. The mixture was then mixed with glacial acetic acid to the constant volume of 10 ml. Using the blank reagent alone as the reference; the optical densities (OD) of the samples were measured at a wavelength of 558 nm, and were converted to the quantity of proteoglycan.

### Detection of type II collagen via immunohistochemistry using streptavidin-biotin complex (SABC) method

The remaining six rabbits in each group were sacrificed following X-ray imaging by ear injection of air. The intervertebral discs (L2-3, L3-4 and L4-5) were separated from lumbar spine. At each time point, nine intervertebral disc specimens were continuously sectioned with a slicing machine (Leike, Hubei, China). The thickness of the sections was 4 µm. The slides were stained with 1:250 mouse anti-human collagen type II 1 (Col2a1) antibody (cat. no. sc-52658; 1:250; Santa Cruz Biotechnology, Inc., Dallas, TX, USA), and stored at 4°C overnight. The secondary antibody staining was performed using 1:1,000 biotinylated rabbit anti-mouse IgG (cat. no. ab6728; 1:1,000; Abcam, Cambridge, UK) and incubated at 37°C for 2 h, and then developed using the SABC kit and DAB reagent (Boster Systems, Inc., Wuhan, China), in accordance with the manufacturer\'s protocol. The expression of Col2al was visualized using a marker index. In each slide, five high magnification visual fields were randomly selected, and the numbers of total cells and positive cells were counted under a fluorescence microscope (GVM-55; Shanghai Precision Instruments Co., Ltd., Shanghai, China). The percentage of positive cells was calculated and averaged for the five visual fields.

### Statistical analysis

Statistical data analysis was performed using SPSS 19.0 statistical software (IBM SPPS, Armonk, NY, USA). The ranked data were confirmed using rank sum tests. The count data were compared using χ^2^ tests. The measurement data are presented as the mean ± standard deviation and were verified using the Kolmogorov-Smirnov test of normality. The data between two groups were compared using an unpaired two-tailed Student\'s t-test. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Determination of the optimal concentration for Wip1 gene vectors

The expression of *Wip1* was observed using a fluorescence microscope as early as 12 h following transfection. The expression peaked 48 h post-transfection. The nucleus pulposus cells were transfected with six different virus concentrations (25, 50, 100, 200, 400 and 800 MOI) for 48 h, and the results from the flow cytometry are shown in [Table I](#tI-mmr-16-06-9487){ref-type="table"}. The results from the fluorescence microscopy showed that the transfection rate of the cells increased at higher concentrations of the virus, with 200 MOI being the minimum dose required to reach the maximum rate of transfection ([Fig. 1A-F](#f1-mmr-16-06-9487){ref-type="fig"}).

### Effect of the Wip1 gene vector on the growth of nucleus pulposus cells

Following separation of the nucleus pulposus cells from the lumbar intervertebral disc, the numbers of living cells were counted using trypan blue staining. The results showed that the percentage of living cells was up to 93%. The cells were seeded into 24-well culture plates and cultured for 15 days, until the cells were fully fused and in good condition. The cell density increased from 1.37×10^5^ to 3.68×10^5^ cells/ml, and the percentage of living cells remained as high as 91%. As shown in [Fig. 2A and B](#f2-mmr-16-06-9487){ref-type="fig"}, no significant differences were found between the virus infection group (200 MOI) and blank control group (0 MOI). As shown in [Fig. 2C](#f2-mmr-16-06-9487){ref-type="fig"}, within 14 days of 200 MOI Ad*Wip1* transfection, the cells continued to grow, and the rate of growth was almost identical with that of the blank control group.

### Expression of AdWip1 in rabbit nucleus pulposus tissues

At 7 days post-transfection of the *Wip1* gene vectors into the nucleus pulposus of rabbit intervertebral discs, the expression of *Wip1* was highest, followed by a gradual decrease. The OD values on days 7, 14, 21 and 28 were 0.0068±0.0031, 0.0057±0.0028, 0.0031±0.0011 and 0.0013±0.0008, respectively. Although the OD value on day 14 was marginally lower, compared with that on day 7, the difference was not significant (P\>0.05). However, the OD values on days 21 and 28 were decreased significantly (P\<0.05), as shown in [Fig. 3A-D](#f3-mmr-16-06-9487){ref-type="fig"}.

### General condition of the rabbits in each group

Following transfection, all rabbits were fed for 4--6 h. At 24 h post-transfection, the rabbits resumed normal diets and activities. All rabbits had normal hair color, adequate reactions to external stimuli, and normal food intake and excrement. All wounds healed in phase I with no animal death. In groups A-C, the rabbits showed marginally slower activity following surgery, however, no significant differences were observed between the rabbits in groups D-F and the normal rabbits. With the passage of time, the activities of rabbits in group A gradually returned to a normal level, whereas the activities of rabbits in groups B and C were slower, and responses to external stimulation were lower than normal.

### X-ray examination

Following surgery for model establishment, the lumbar spine was assessed using X-ray examination. It was found that the intervertebral space was relatively normal, the bones of the upper and lower plates showed sclerosis, and the anterior vertebral bone showed osteoproliferation, as shown in [Fig. 4A-C](#f4-mmr-16-06-9487){ref-type="fig"}. At different time points, the heights of intervertebral disc spaces in groups A-C differed from those in groups D-F (all P\<0.05). The values among groups D-F were similar (P\>0.05). At 3 weeks following surgery, no significant differences were found among groups A-C (all P\>0.05). After 6 and 9 weeks, the heights of the intervertebral disc spaces in group A were significantly different, compared with those in groups B and C (all P\<0.05), as shown in [Table II](#tII-mmr-16-06-9487){ref-type="table"}.

### Determination of proteoglycan content in the nucleus pulposus

At 3, 6 and 9 weeks following the injection of Ad*Wip1*, the proteoglycan content in the nucleus pulposus of the intervertebral discs (L2-3, L3-4 and L4-5) were measured. The content of proteocylcan in group A remained higher, compared with the content in groups B and C (P\<0.05). The content among groups D-F was similar (P\>0.05). The results in group A were similar to those in groups D-F (all P\>0.05). However, the results in groups B and C differed from those in groups E and F (all P\<0.05; [Table III](#tIII-mmr-16-06-9487){ref-type="table"}).

### Type II collagen

At 3, 6 and 9 weeks following the injection of Ad*Wip1*, the levels of type II collagen were measured in the nucleus pulposus of the intervertebral discs (L2-3, L3-4 and L4-5). The results are shown in [Table IV](#tIV-mmr-16-06-9487){ref-type="table"}. The content of type II collagen differed in group A, compared with the content in groups B and C (P\<0.05). The results from groups B and C were similar (P\>0.05). The results among groups D-F were similar (P\>0.05). The type II collagen contents in groups A-C were lower compared with those in groups D-F (all P\<0.05).

Discussion
==========

LDD is primarily manifested as bone hyperplasia, end plate sclerosis and intervertebral disc space narrowing, resulting in back pain ([@b17-mmr-16-06-9487]). Currently, surgery and non-surgical treatments are used in parallel to alleviate pain, however, it is difficult to always achieve satisfactory results. In addition, there is a risk associated with LDD surgery, which may worsen the degeneration of adjacent tissues ([@b18-mmr-16-06-9487]). As current understanding the cause of LDD at the genetic level has improved, innovative treatment strategies may become available for LDD.

The experimental results in the present study showed that the transfection of Ad*Wip1* into New Zealand white rabbits caused significant recovery from LDD, but could not completely eliminate the disease. Intervertebral discs contain three major components: A gel-like nucleus pulposus to resist internal pressure, fiber rings to resist external pressure, and cartilage end plates ([@b19-mmr-16-06-9487]). It has been shown that LDD is closely associated with reduced height of the intervertebral disc ([@b20-mmr-16-06-9487]). During the degeneration of lumbar intervertebral discs, modic changes generally occur in patients, including degeneration, damage to cartilage endplates in the regeneration and vascular granulation regions, fractures, and increased signal intensity in bone tissues and granulation tissues ([@b21-mmr-16-06-9487]). These external stimuli can trigger the DNA damage response (DDR) in cells, which has a dual effect: It prevents the propagation of DNA damage intracellularly, as DDR inhibits DNA replication and promotes the decomposition of damaged DNA; however, DDR tends to coordinate the internal repair of DNA in order to maintain the integrity of the genome ([@b22-mmr-16-06-9487]). Therefore, in addition to the DDR repairing damage, it can also lead to the aging of intervertebral disc cells by inhibiting DNA replication. *Wip1* is an important molecule, which inhibits the activity of DDR-associated molecules through dephosphorylation, causing the timely termination of DDR ([@b23-mmr-16-06-9487]--[@b25-mmr-16-06-9487]). The experimental results of the present study showed that the intervertebral disc height in the groups transfected with Ad*Wip1* increased, indicating that the expression of *Wip1* improved the prognosis of LDD.

The results of the present study also showed that the type II collagen and proteoglycan contents were increased in the groups transfected with Ad*Wip1*. The extracellular matrix of the intervertebral disc primarily contains collagen (predominantly type II collagen), proteoglycan, elastin and water. In each layer of the fiber rings, grids are formed by elastin and collagen fitting closely, and proteoglycan is integrated into these grids ([@b26-mmr-16-06-9487]). It has also been shown that the aging of nucleus pulposus cells is the primary cause of intervertebral disc degeneration ([@b27-mmr-16-06-9487]). Following the occurrence of disc degeneration, the separation lines between the fiber rings and nucleus pulposus becomes less clear, the ability of the nucleus pulposus to synthesize proteins and sugar is decreased, the arrangements and types of collagen are altered, and the corresponding biological functions of the nucleus pulposus is significantly weakened ([@b28-mmr-16-06-9487]). It has been shown that the expression of *Wip1* prevented the premature senescence of cells ([@b29-mmr-16-06-9487]). Therefore, transfection of the *Wip1* gene into cells may inhibit the senescence of nucleus pulposus cells, and the increased levels of proteoglycan and type II collagen contents may assist in the treatment of LDD.

In conclusion, *Wip1* gene vectors showed promising clinical efficacy for the treatment of LDD in the present study. The optimum concentration of *Wip1* gene vectors was 200 MOI. The AAV delivery of the *Wip1* gene may become a novel targeted approach to treat LDD. However, the sample size in the present study was limited, therefore, the clinical significance of the results requires further verification in future experiments with larger sample sizes.

This study was supported in part by the National Natural Science Foundation of China (grant no. 8127135).

![Transfection of nucleus pulposus cells by Ad*Wip1* at different viral concentrations. Images were captured under a fluorescence microscope (magnification, ×100). (A) 25 MOI; (B) 50 MOI; (C) 100 MOI; (D) 200 MOI; (E) 400 MOI; (F) 800 MOI. Ad, adenovirus; *Wip1*, wild-type *p53*-induced protein phosphatase 1; MOI, multiplicity of infection.](MMR-16-06-9487-g00){#f1-mmr-16-06-9487}

![Numbers of nucleus pulposus cells. (A) Virus infection group and (B) blank control group (magnification, ×100). (C) Growth curve of nucleus pulposus cells in the virus infection group (200 MOI) and blank control group (0 MOI). MOI, multiplicity of infection.](MMR-16-06-9487-g01){#f2-mmr-16-06-9487}

![At different time points following Ad*Wip1* transfection, the nucleus pulposus tissues of the intervertebral disc were made into slides and observed under a fluorescence microscope (magnification, ×200), (A) 7 days post-transfection; (B) 14 days post-transfection; (C) 21 days post-transfection; (D) 28 days post-transfection. Ad, adenovirus; *Wip1*, wild-type *p53*-induced protein phosphatase 1.](MMR-16-06-9487-g02){#f3-mmr-16-06-9487}

![X-ray results of intervertebral space degeneration in the model group. The images present (A) a narrowing of the intervertebral space, (B) osteophyte formation and (C) alterations in the cartilage endplate. Red arrows indicate the intervertebral space following the establishment of the model.](MMR-16-06-9487-g03){#f4-mmr-16-06-9487}

###### 

Flow cytometry results.

  Virus concentration (multiplicity of infection)   Positive cells (%)
  ------------------------------------------------- --------------------
  25                                                21.32±2.71
  50                                                45.56±2.91
  100                                               66.11±1.06
  200                                               89.65±2.47
  400                                               80.41±3.32
  800                                               74.19±3.11

###### 

X-ray results showing the height of intervertebral disc spaces at different time points.

                 Height of intervertebral disc space (mm)               
  ---------- --- ------------------------------------------ ----------- -----------
  Ad*Wip1*   A   0.75±0.09                                  0.63±0.08   0.73±0.08
             B   0.61±0.08                                  0.42±0.05   0.56±0.05
             C   0.67±0.08                                  0.46±0.06   0.52±0.06
  Control    D   0.91±0.10                                  0.83±0.10   0.90±0.08
             E   0.92±0.13                                  0.89±0.09   0.93±0.10
             F   0.97±0.12                                  0.90±0.12   0.94±0.11

Data are presented as the mean ± standard deviation. Ad*Wip1*, adenovirus vector for wild-type *p53*-induced protein phosphatase 1.

###### 

Proteoglycan content in nucleus pulposus cells of the intervertebral discs in each group.

  Group   Weeks post-injection   L2-3 (mg/g)   L3-4 (mg/g)   L4-5 (mg/g)
  ------- ---------------------- ------------- ------------- -------------
  A       3                      5.06±0.31     5.19±0.22     5.13±0.19
          6                      4.99±0.28     5.07±0.18     5.09±0.16
          9                      4.84±0.31     4.91±0.21     5.03±0.22
  B       3                      4.62±0.17     4.78±0.12     4.68±0.14
          6                      4.58±0.18     4.65±0.20     4.59±0.12
          9                      4.49±0.11     4.38±0.17     4.45±0.11
  C       3                      4.58±0.28     4.69±0.16     4.62±0.15
          6                      4.45±0.21     4.58±0.19     4.49±0.14
          9                      4.42±0.17     4.49±0.21     4.40±0.13
  D       3                      4.88±0.25     4.92±0.26     4.86±0.25
          6                      4.76±0.31     4.81±0.29     4.72±0.26
          9                      4.68±0.21     4.74±0.31     4.63±0.26
  E       3                      5.10±0.24     5.21±0.32     5.18±0.28
          6                      5.01±0.29     5.09±0.28     5.06±0.31
          9                      4.92±0.24     4.98±0.31     4.97±0.33
  F       3                      5.17±0.26     5.23±0.32     5.22±0.30
          6                      5.06±0.23     5.11±0.26     5.10±0.33
          9                      4.98±0.32     5.04±0.24     5.03±0.29

###### 

Type II collagen content in nucleus pulposus cells of intervertebral discs in each group.

  Group   Weeks post-injection   L2-3 (mg/g)   L3-4 (mg/g)   L4-5 (mg/g)
  ------- ---------------------- ------------- ------------- -------------
  A       3                      119.56±4.62   121.25±4.37   123.33±5.69
          6                      112.33±5.15   120.24±5.63   120.66±4.44
          9                      104.43±4.18   105.76±4.38   106.75±4.48
  B       3                      87.33±4.26    84.75±3.77    84.42±3.23
          6                      85.41±3.93    83.59±3.74    80.12±3.03
          9                      79.56±3.02    82.35±3.21    78.52±3.16
  C       3                      86.81±3.95    85.77±4.11    85.52±4.12
          6                      84.38±3.86    83.58±3.81    84.87±3.97
          9                      79.67±2.99    82.86±3.05    81.58±3.14
  D       3                      140.13±6.34   141.36±6.35   140.37±6.42
          6                      137.43±5.63   139.74±5.28   138.49±6.54
          9                      136.58±6.15   137.45±6.36   136.32±5.85
  E       3                      138.43±6.14   140.31±5.42   140.34±6.15
          6                      136.15±6.32   138.21±6.54   137.69±5.81
          9                      134.36±5.82   134.14±6.32   134.43±6.94
  F       3                      141.51±5.64   142.36±6.58   141.11±6.84
          6                      138.37±6.21   141.22±6.28   139.54±5.76
          9                      137.46±6.36   138.62±6.83   137.44±6.42

Data are presented as the mean ± standard deviation.
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